Checkmate 9la asco 202112/6/2023 In the phase III CheckMate 743 study ( NCT02899299), first-line nivolumab plus ipilimumab significantly improved overall survival (OS) versus chemotherapy in patients with unresectable malignant pleural mesothelioma (MPM). 20 Thoracic Oncology Department, Early Phases Unit-CIC INSERM 1425-CLIP2 Paris Nord, Bichat-Claude Bernard Hospital, AP-HP, University Cancer Institute Paris, Paris, France.19 Department of Informatics and Predictive Sciences, Bristol Myers Squibb, Princeton, USA.18 Translational Medicine, Bristol Myers Squibb, Princeton, USA.17 Biostatistics, Bristol Myers Squibb, Princeton, USA.16 Oncology Clinical Development, Bristol Myers Squibb, Princeton, USA.15 Lung Unit, Royal Marsden Hospital, London, UK Institute of Cancer Research, London, UK.14 Division of Medical Oncology, Mayo Clinic, Rochester, USA.13 Department of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, USA.12 Department of Medical Oncology, Okayama Rosai Hospital, Okayama, Japan.11 Medical School, University of Western Australia and Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Australia.10 Department of Thoracic Oncology, Netherlands Cancer Institute and Leiden University Medical Center, Amsterdam, The Netherlands.9 Medical Oncology, Institut de Cancérologie de l'Ouest, Site René Gauducheau, Boulevard Jacques Monod, Saint-Herblain Cedex, France.8 Department of Pulmonology, Centre Hospitalier Intercommunal de Créteil, Créteil, France. 7 The Sunrise Centre, Royal Cornwall Hospitals NHS Trust, Truro, UK.6 Medical Oncology, Medical School, Dicle University, Diyarbakir, Turkey.5 Aix Marseille University, APHM, INSERM, CNRS, CRCM, Hôpital Nord, Multidisciplinary Oncology and Therapeutic Innovations Department, Marseille, France.4 Pulmonary and Thoracic Oncology Department, Hôpital Côte de Nacre C H U Caen, Caen, France.3 Pulmonary Medicine, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.Electronic address: 2 Pulmonary and Thoracic Oncology, University of Lille, CHU Lille, INSERM U1189, OncoThAI, Lille, France. 1 Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |